A Study of IMR-687 in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Sickle-Cell; Hb-SCSickle Cell DiseaseSickle Beta 0 Thalassemia
- Interventions
- Drug: Placebo Oral Capsule
- First Posted Date
- 2016-12-20
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Cardurion Pharmaceuticals, Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT02998450
- Locations
- 🇺🇸
Quintiles, Overland Park, Kansas, United States
© Copyright 2025. All Rights Reserved by MedPath